Patent 9260379 was granted and assigned to Ocera Therapeutics on February, 2016 by the United States Patent and Trademark Office.
Disclosed herein are processes for making L-ornithine phenyl acetate. The process may include, for example, intermixing a halide salt of L-ornithine with silver phenyl acetate. The process may also include forming a phenyl acetate salt in situ. The present application also relates to various compositions obtained from these processes, including crystalline forms.